Abstract
This Frost & Sullivan research service titled Strategic Analysis of the Kenyan Diabetes Markets provides an overview of the Kenyan healthcare industry in the context of diabetes treatment drugs as divided between type I and type II diabetics. In this research, Frost & Sullivan' s expert analysts thoroughly examine the key industry challenges, drivers, restraints and trends. Also provided are revenue forecasts and strategic recommendations.
This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.
Table of Contents
- 1. Executive Summary
- 2. Research Objectives, Scope and Methodology
- 3. Strategic Analysis of the Kenyan Diabetes Markets
- 4. List of Key Industry Participants
- 5. Decision Support Databases
